GlaxoSmithKline PLC Company Profile | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | GlaxoSmithKline PLC

GlaxoSmithKline PLC

GlaxoSmithKline PLC
Stock Exchange	Other OTC
EPS	$1.02
Market Cap	$100.92 B
Shares Outstanding	4.96 B
Public Float	-

GlaxoSmithKline PLC
Stock Exchange	Xetra Stock Exchange
EPS	EUR0.89
Market Cap	EUR89.5 B
Shares Outstanding	4.96 B
Public Float	-

GlaxoSmithKline PLC
Stock Exchange	London Stock Exchange
EPS	GBP0.79
Market Cap	GBP80.57 B
Shares Outstanding	4.96 B
Public Float	4.83 B

GlaxoSmithKline PLC ADR
Stock Exchange	New York Stock Exchange
EPS	$2.05
Market Cap	$100.55 B
Shares Outstanding	2.49 B
Public Float	-

Profile

Address	980 Great West Road Brentford Greater London TW8 9GS United Kingdom
Employees	-
Website	http://gsk.com
Updated	07/08/2019
GlaxoSmithKline Plc is a global healthcare company which engages in developing, manufacturing, and marketing of pharmaceutical products including vaccines, over the counter medicines and health-related consumer products. It operates through the following segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases.

Financials

Philip Roy Hampton

Non-Executive Chairman

Emma Walmsley

Chief Executive Officer & Executive Director